LLY

916.49

-1.52%↓

JNJ

237.15

-0.37%↓

ABBV

208.28

-5.27%↓

NVS

149.76

-3.06%↓

AZN

188.42

-1.47%↓

LLY

916.49

-1.52%↓

JNJ

237.15

-0.37%↓

ABBV

208.28

-5.27%↓

NVS

149.76

-3.06%↓

AZN

188.42

-1.47%↓

LLY

916.49

-1.52%↓

JNJ

237.15

-0.37%↓

ABBV

208.28

-5.27%↓

NVS

149.76

-3.06%↓

AZN

188.42

-1.47%↓

LLY

916.49

-1.52%↓

JNJ

237.15

-0.37%↓

ABBV

208.28

-5.27%↓

NVS

149.76

-3.06%↓

AZN

188.42

-1.47%↓

LLY

916.49

-1.52%↓

JNJ

237.15

-0.37%↓

ABBV

208.28

-5.27%↓

NVS

149.76

-3.06%↓

AZN

188.42

-1.47%↓

Inicio・Lista de Acciones・DaVita Inc

DaVita Inc

Cerrado

SectorSanidad

149.07 -0.61

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

148.76

Máximo

152.14

Métricas clave
By Trading Economics
Ingresos	769M 1.1B
Ventas	200M 3.6B
P/B Media del Sector	15.569 57.833
BPA	3.4
Margen de beneficios	29.801
Empleados	78,000
EBITDA	81M 718M

Recomendaciones
By TipRanks
Recomendaciones	Neutral
Estimación a 12 Meses	+9.18% upside

Dividendos
By Dow Jones
Próximas Ganancias	11 may 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	2B 9.9B
Apertura anterior	149.68
Cierre anterior	149.07

Noticias sobre sentimiento de mercado

By Acuity

20%

80%

34 / 351 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

142.36 / 144.275 Soporte y Resistencia

DaVita Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

29 dic 2025, 06:30 UTC

Adquisiciones, fusiones, absorciones

Berkshire's Buffett Is Stepping Down. Why Little Will Change and Why That's OK. -- Barrons.com

21 mar 2025, 08:19 UTC

Charlas de Mercado

Fresenius Medical Care's Revenue Estimates Lowered by Jefferies on U.S. Volume Concerns -- Market Talk

Comparación entre iguales

Cambio de precio

DaVita Inc previsión

Precio Objetivo

By TipRanks

9.18% repunte

Estimación a 12 Meses

Media 162.5 USD 9.18%

Máximo 190 USD

Mínimo 144 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para DaVita Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

5 ratings

Comprar

Mantener

Vender

De acuerdo con 5 analistas que ofrecen calificaciones bursátiles a para DaVita Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

142.36 / 144.275Soporte y Resistencia

Recent bullish events outweigh bearish events.

All events are bearish.

Recent bearish events outweigh bullish events.

Sentimiento

By Acuity

34 / 351 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de DaVita Inc

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.